Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ARVN

Arvinas Inc

May 22 • 04:00PM ET

9.09

-0.01 -0.11 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR CCCC NRIX GLUE RLAY

| Held by: VTI IWM VXF IWN IBB XPH SCHA VTWO PRFZ VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.26	Insider Own	16.70%	Shs Outstand	64.50M	Perf Week	0.11%
Market Cap	586.50M	Forward P/E	-	EPS next Y	-3.42	Insider Trans	-0.90%	Shs Float	54.09M	Perf Month	-12.76%
Enterprise Value	-19.80M	PEG	-	EPS next Q	-0.40	Inst Own	75.90%	Short Float	8.17%	Perf Quarter	-26.10%
Income	-221.30M	P/S	6.56	EPS this Y	-151.21%	Inst Trans	-2.23%	Short Ratio	4.81	Perf Half Y	-21.16%
Sales	89.40M	P/B	1.52	EPS next Y	-19.40%	ROA	-26.85%	Short Interest	4.42M	Perf YTD	-23.36%
Book/sh	6.00	P/C	0.95	EPS next 5Y	-	ROE	-42.28%	52W High	14.51 -37.35%	Perf Year	40.49%
Cash/sh	9.53	P/FCF	-	EPS past 3/5Y	40.13% 17.70%	ROIC	-56.25%	52W Low	6.05 50.12%	Perf 3Y	-62.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	25.96% 64.50%	Gross Margin	94.41%	Volatility	5.17% 6.13%	Perf 5Y	-86.33%
Dividend TTM	-	EV/Sales	-0.22	EPS Y/Y TTM	-397.92%	Oper. Margin	-278.41%	ATR (14)	0.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.44	Sales Y/Y TTM	-79.06%	Profit Margin	-247.54%	RSI (14)	37.41	Recom	2.11
Dividend Gr. 3/5Y	- -	Current Ratio	5.44	EPS Q/Q	-178.93%	SMA20	-6.73%	Beta	1.78	Target Price	15.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-91.74%	SMA50	-13.11%	Rel Volume	0.85	Prev Close	9.10
Employees	246	LT Debt/Eq	0.02	Earnings	May 12 BMO	SMA200	-14.28%	Avg Volume	918.84K	Price	9.09
IPO	Sep 27, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.56% -6.09%	Trades		Volume	778,412	Change	-0.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)